Randomized control study to evaluate the efficacy of Denosumab versus zoledronic acid for treatment of bone metastases in men with prostate cancer
Not Applicable
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000012967
- Lead Sponsor
- Chiba Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who had prior bisphosphonate 2.Patients who are on hemodialysis 3.Patients who are treated with chemotherapy 4.Patients with poorly controlled hepatic disorder or renal dysfunction or diabetes 5.Patients who are receiving or planning treatment of tooth extraction or dental implant for oral infeciton 6.Patients who considered inappropriate for this trial by physicians
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method